GW273225

DRUG3 trials

Sponsors

GlaxoSmithKline

Conditions

Bipolar DisorderEpilepsy

Phase 1

Oral Contraceptive Interaction Study for GW273225

TerminatedNCT00483535

GlaxoSmithKlineBipolar Disorder

Start: 2007-03-07End: 2007-11-16Updated: 2017-08-08

Study to Assess the Effect of Food on the Concentration of GW273225 in the Body of Healthy Male and Female Volunteers

CompletedNCT00501865

GlaxoSmithKlineBipolar Disorder

Start: 2007-08-06End: 2007-10-11Updated: 2017-08-04

Phase 2

GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

WithdrawnNCT00567424

GlaxoSmithKlineEpilepsy

Start: 2006-07-31End: 2008-03-31Updated: 2013-04-04